Skip to content
Clinical Trials – home
BelgiumBack to Belgium

Clinical trials in Koekelberg – page 64

2 112 clinical trials in Koekelberg, Belgium. Every trial is listed in the EU Clinical Trials Register and updated daily.

Koekelberg at a glance
2 112
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

2 112 trials in Koekelberg

Open in trial search

Study on Tioguanine and Drug Combination for Patients Aged 0-45 with Newly Diagnosed Acute Lymphoblastic Leukemia

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years
  • Substances:Blinatumomab
  • Sponsor:Karolinska University Hospital

Study on Posaconazole and Fluconazole for Preventing Fungal Infections in Patients with Acute Myeloid Leukemia

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Fluconazole
  • Sponsor:Centre Hospitalier Universitaire Vaudois

Study of petosemtamab alone or with drug combination for patients with advanced colorectal cancer and other solid tumors

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:Genmab A/S

Study of Sacituzumab Govitecan and Pembrolizumab for Patients with Triple Negative Breast Cancer with Residual Disease After Surgery and Therapy

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Gilead Sciences Inc.

Study on Citalopram for Patients with Reflux Hypersensitivity or Functional Heartburn Not Fully Helped by Proton Pump Inhibitors

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years
  • Substances:Citalopram
  • Sponsor:UZ Leuven

Neoplasm

Recruiting

Study on Long-Term Safety of BI 907828 for Patients with Solid Tumors Who Previously Participated in a Study with This Medicine

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Brigimadlin
  • Sponsor:Boehringer Ingelheim Espana S.A.

Dyspepsia

Recruiting

Study on Budesonide and Mannitol for Treating Inflammation in Patients with Functional Dyspepsia

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:UZ Leuven

Study on Blinatumomab, Ponatinib, and Isatuximab for Adults Aged 18-65 with Newly Diagnosed Acute Lymphoblastic Leukemia or T-Cell Lymphoblastic Lymphoma

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Blinatumomab
  • Sponsor:Assistance Publique Hopitaux De Paris

Study on Imaging Non-Small Cell Lung Cancer Using 68GaNOTA-Anti-MMR VHH2 in Patients

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:68GaNOTA-anti-MMR-VHH2
  • Sponsor:UZ Brussel

Study of Dasatinib and Venetoclax for Children with Relapsed or Refractory Leukemia or Lymphoma with MAPK/SRC Pathway Mutation

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years
  • Substances:Dasatinib
  • Sponsor:Prinses Maxima Centrum voor Kinderoncologie B.V.

Study on Early Drug Withdrawal in Children with Juvenile Idiopathic Arthritis Using Secukinumab and Drug Combination for Those in Clinical Remission

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years
  • Substances:Abatacept
  • Sponsor:IRCCS Istituto Giannina Gaslini

Study on the Effects of Filgotinib for Children and Teenagers with Moderate to Severe Ulcerative Colitis

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years
  • Substances:Filgotinib
  • Sponsor:Alfasigma S.p.A.

Other cities in Belgium

The busiest research cities in the country

All 164 cities in Belgium

Clinical research in Koekelberg

What the registry says about research in the country

01 Gastroenterology Research

Clinical research focusing on optimizing treatment strategies for patients with functional dyspepsia and related gastrointestinal conditions.

  • Proton Pump Inhibitor Management
  • Digestive Health Optimization
  • Treatment De-escalation Studies

Investigating innovative approaches to reduce long-term medication dependency while maintaining effective symptom control for patients with heartburn and reflux conditions.

02 Primary Care Innovation

Evaluating novel deprescribing strategies in the primary care setting to improve patient outcomes and medication management.

  • On-demand Medication Protocols
  • Alternative Treatment Approaches
  • Patient-centered Care Solutions

Research aimed at developing evidence-based approaches for medication reduction while maintaining quality of life and symptom control.

03 Therapeutic Strategy Development

Comparative research examining different approaches to medication management in chronic conditions.

  • Medication Optimization
  • Alternative Therapy Evaluation
  • Long-term Care Strategies

Exploring the effectiveness of various therapeutic approaches including alginate formulations and flexible dosing schedules.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.